Ciliary microtubule inner protein 6 (CIMIP6)

Ciliary microtubule inner protein 6 (CIMIP6), associated with the gene C2orf73, is proposed as a protein located within the inner lumen of ciliary microtubules, classified in the family of microtubule inner proteins (MIPs). MIPs are implicated in maintaining the stability and specialized assembly of cilia and flagella, thus supporting the axonemal structure essential for ciliary motility[1][2][3][4]. However, there is no published, peer-reviewed functional characterization, disease linkage, or established role for CIMIP6 specifically in humans. Most recent structural and proteomic studies of MIPs in cilia have not identified CIMIP6/C2orf73 as a functionally validated structural component, nor as a therapeutic target, receptor, or biomarker[1][2][3][4]. Thus, its status as a canonical or actionable drug target is currently unsupported. Key notes: - The broader class of microtubule inner proteins (MIPs) contribute to ciliary and flagellar microtubule architecture and play a structural (rather than receptor or enzymatic) role[1][2][3][4]. - There is no evidence CIMIP6 itself participates in signaling, acts as a therapeutic target, or is connected to specific ciliary disorders. - Gene/protein entries such as C2orf73/FLJ40298 may appear in databases as “uncharacterized protein”, reflecting their predicted existence without experimental validation or named function. - There is no documented drug interaction, mechanism of action, or biomarker status for CIMIP6/C2orf73. If you are seeking targets relevant for ciliary diseases (such as primary ciliary dyskinesia), current validated MIPs include proteins like FAP52, FAP276, PACRG, and others, according to recent high-resolution proteomic and structural studies—none of which are referred to as CIMIP6 or C2orf73[1][2][3][4].

Other names

C2orf73FLJ40298uncharacterized protein C2orf73CIMIP6